Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to generate long-term safety, tolerability and efficacy data for
AFQ056 in eligible adolescent patients with FXS who have participated in the CAFQ056B2214
study, the PK study CAFQ056B2131, or another study of AFQ056 which included FXS patients
below 18 years of age provided the patient is at least 12 years of age at the time of entry
into the current study.